Regulatory News
Thursday, June 23, 2016
BRIEF-Gilead says European Commission grants marketing authorization for Odefsey
* European Commission grants marketing authorization for
Gilead's single tablet regimen Odefsey (emtricitabine,
rilpivirine, tenofovir alafenamide) for the treatment of HIV
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment